Lundbeck Canada Inc. et al. v. ratiopharm Inc. et al., (2009) 357 F.T.R. 75 (FC)

This document cites

• Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
• Solvay Pharma Inc. et al. v. Apotex Inc. et al., (2008) 323 F.T.R. 1 (FC)
• Aventis Pharma Inc. v. Apotex Inc. et al., (2005) 278 F.T.R. 1 (FC)
• Halford v. Seed Hawk Inc., (2006) 353 N.R. 60 (FCA)
• Apotex Inc. and Novopharm Ltd. v. Wellcome Foundation Ltd., (2000) 262 N.R. 137 (FCA)



See all quotations

• AB Hassle v. Can., (2000) 256 N.R. 172 (FCA)
• Eli Lilly Canada Inc. v. Apotex Inc. et al., (2008) 323 F.T.R. 56 (FC)
• Eli Lilly Canada Inc. v. Apotex Inc. et al., 2009 FCA 97
• Aventis Pharma Inc. et al. v. Pharmascience Inc. et al., (2006) 296 F.T.R. 141 (FC)
• Whirlpool Corp. et al. v. Camco Inc. et al., (2000) 263 N.R. 88 (SCC)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., (2007) 366 N.R. 347 (FCA)
• Laboratoires Servier et al. v. Apotex Inc. et al., (2008) 332 F.T.R. 193 (FC)
• Abbott Laboratories et al. v. Canada (Minister of Health) et al., 2009 FCA 94
• Free World Trust v. Électro Santé Inc. et al., (2000) 263 N.R. 150 (SCC)
• Sanofi-Aventis Canada Inc. et al. v. Novopharm Ltd. et al., (2007) 366 N.R. 231 (FCA)
• Tsai v. Klug et al., (2006) 358 N.R. 391 (Motion)
• Pfizer Can. Inc. v. Novopharm, 2005 FCA 270
• Aventis Pharma Inc. v. Apotex Inc. et al., 2006 FCA 64
• Janssen-Ortho Inc. et al. v. Apotex Inc. et al., (2009) 392 N.R. 71 (FCA)
• Janssen-Ortho Inc. et al. v. Novopharm Ltd., 2007 FCA 217
• Searle (G.D.) & Co. et al. v. Novopharm Ltd. et al., 2007 FC 81
• AB Hassle et al. v. Genpharm Inc. et al., (2003) 243 F.T.R. 6 (FC)
• Janssen-Ortho Inc. et al. v. Apotex Inc. et al., (2008) 332 F.T.R. 1 (FC)
• ratiopharm inc. v. Pfizer Ltd., (2009) 350 F.T.R. 250 (FC)
• Laboratoires Servier et al. v. Apotex Inc. et al., (2009) 392 N.R. 96 (FCA)
• Searle (G.D.) & Co. et al. v. Novopharm Ltd. et al., (2007) 361 N.R. 290 (FCA)
• Bristol-Myers Squibb Canada Co. et al. v. Apotex Inc. et al., (2009) 342 F.T.R. 161 (FC)
• Abbott Laboratories et al. v. Canada (Minister of Health) et al., (2007) 361 N.R. 308 (FCA)
• Apotex Inc. and Novopharm Ltd. v. Wellcome Foundation Ltd., (2002) 296 N.R. 130 (SCC)
• Abbott Laboratories et al. v. Canada (Minister of Health) et al., 2008 FC 1359
• Aventis Pharma Inc. v. Pharmascience, 2006 FCA 229
• AB Hassle et al. v. Genpharm Inc. et al., 2004 FCA 413
• Eli Lilly Canada Inc. v. Novopharm Ltd. et al., (2009) 346 F.T.R. 42 (FC)
• Aventis Pharma Inc. et al. v. Apotex Inc. et al., 2005 FC 1461
• Consolboard Inc. v. MacMillan Bloedel (Saskatchewan) Ltd., (1981) 35 N.R. 390 (SCC)